Medprin Regenerative Value At Risk
| 301033 Stock | | | 60.71 -1.88 -3.00% |
Historical market data for Medprin Regenerative Medical forms the basis of the Value At Risk indicator shown here. The calculation draws on time-series market data across available periods. Medprin Regenerative has a market cap of 4.56 B, operating margin of 36.93%, ROE of 14.41%. Portfolio-level context is available through
Trending Equities. This suggests a position in Medprin Regenerative Medical. This appears in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
Medprin Regenerative Medical has current Value At Risk of
-3.98. Value At Risk (or VAR) is a statistical technique used to measure the level of financial risk of investment instrument over a specific time frame. It is a widely used measure of the risk of loss on a specific investing instrument.
Value At Risk | = | ER[a] x N | + | (Z-SCORE x STD x SQRT (N)) |
| = | -3.98 | |
Value At Risk Peers Comparison
Value At Risk Relative To Other Indicators
Medprin Regenerative Medical is rated
below average in value at risk among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors .
Value At Risk is used by risk managers in order to measure and control the level of risk which the firm undertakes. The risk manager job is to ensure that risks are not taken beyond the level at which the firm can absorb the losses of a probable worst outcome. VAR can be defined as the loss level that will not be exceeded with a certain confidence level during a certain period of time.
Compare Medprin Regenerative to Peers
Other Technical Indicators